$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223023833 Filed on July 06, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$485.6K	$0.00	$0.00
YoY Change	2760.9%	-100.0%	-100.0%
Cost Of Revenue	$999.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Gross Profit	$484.6K	$0.00	$0.00
YoY Change	2755.01%	-100.0%	-100.0%
Gross Profit Margin	99.79%
Selling, General & Admin	$727.8K	$4.193M	$4.583M
YoY Change	-51.87%	186.28%	-1.6%
% of Gross Profit	150.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$29.75K	$13.23K	$52.94K
YoY Change	122.48%	-7.87%	6.58%
% of Gross Profit	6.14%
Operating Expenses	$727.8K	$4.193M	$4.583M
YoY Change	-51.87%	186.28%	-1.6%
Operating Profit	-$243.2K	-$4.193M	-$4.583M
YoY Change	-83.74%	304.88%	9.05%
Interest Expense	$431.4K	-$1.989M	-$1.989M
YoY Change	91.87%	374.48%	109.17%
% of Operating Profit
Other Income/Expense, Net	-$135.5K	$540.00	$540.00
YoY Change	-62.91%		-99.41%
Pretax Income	-$378.7K	-$10.42M	-$10.42M
YoY Change	-79.65%	616.14%	105.8%
Income Tax
% Of Pretax Income
Net Earnings	-$378.7K	-$10.42M	-$10.42M
YoY Change	-79.65%	616.14%	105.8%
Net Earnings / Revenue	-77.98%
Basic Earnings Per Share	-$0.01		-$0.29
Diluted Earnings Per Share	-$0.01	-$0.29	-$0.29
COMMON SHARES
Basic Shares Outstanding	64.94M shares	36.80M shares	35.61M shares
Diluted Shares Outstanding	61.93M shares		35.61M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.04K	$49.37K	$49.37K
YoY Change	841.05%	-12.76%	-12.76%
Cash & Equivalents	$52.04K	$49.37K
Short-Term Investments
Other Short-Term Assets	$8.840K	$49.20K	$49.20K
YoY Change	-95.64%	-80.45%	-80.45%
Inventory
Prepaid Expenses
Receivables	$1.674M	$0.00	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.735M	$98.57K	$98.57K
YoY Change	224.04%	-84.16%	-84.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.237M	$1.069M	$1.069M
YoY Change	43.0%	-45.84%	-45.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$49.71K	$0.00	$0.00
YoY Change	-92.32%		-100.0%
Total Long-Term Assets	$3.287M	$1.069M	$1.069M
YoY Change	-38.54%	-79.58%	-79.58%
TOTAL ASSETS
Total Short-Term Assets	$1.735M	$98.57K	$98.57K
Total Long-Term Assets	$3.287M	$1.069M	$1.069M
Total Assets	$5.022M	$1.168M	$1.168M
YoY Change	-14.64%	-80.07%	-80.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.771M	$864.5K	$864.5K
YoY Change	11.59%	-47.81%	-47.81%
Accrued Expenses	$844.5K	$485.7K	$485.7K
YoY Change
Deferred Revenue	$93.38K	$85.41K
YoY Change	-71.74%	-32.57%
Short-Term Debt	$9.547M	$1.845M	$1.845M
YoY Change	867.82%	121.01%	121.01%
Long-Term Debt Due	$1.890M	$1.886M	$1.886M
YoY Change	-9.9%	1734.97%	1734.97%
Total Short-Term Liabilities	$32.47M	$5.719M	$5.719M
YoY Change	546.55%	108.64%	108.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.47M	$5.719M	$5.719M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$32.47M	$5.719M	$5.719M
YoY Change	546.55%	27.75%	27.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.90M	-$25.10M
YoY Change	54.14%	70.7%
Common Stock	$64.94K	$43.50K
YoY Change	79.71%	36.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$300.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$28.05M	-$4.551M	-$4.551M
YoY Change
Total Liabilities & Shareholders Equity	$5.022M	$1.168M	$1.168M
YoY Change	-14.64%	-80.07%	-80.07%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$378.7K	-$10.42M	-$10.42M
YoY Change	-79.65%	616.14%	105.8%
Depreciation, Depletion And Amortization	$29.75K	$13.23K	$52.94K
YoY Change	122.48%	-7.87%	6.58%
Cash From Operating Activities	-$325.5K	-$22.02K	-$528.1K
YoY Change	-2306.58%	-93.37%	-49.01%
INVESTING ACTIVITIES
Capital Expenditures	$35.33K	$95.40K	$539.9K
YoY Change	-117.04%	-133.98%	-203.43%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$35.33K	-$95.40K	-$539.9K
YoY Change	-82.96%	-66.02%	-25.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$16.30K
YoY Change			-99.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	213.4K	70.95K	1.061M
YoY Change	4309.92%	-319.8%	-41.11%
NET CHANGE
Cash From Operating Activities	-325.5K	-22.02K	-528.1K
Cash From Investing Activities	-35.33K	-95.40K	-539.9K
Cash From Financing Activities	213.4K	70.95K	1.061M
Net Change In Cash	-147.4K	-46.47K	-7.220K
YoY Change	-21.51%	-92.8%	-116.63%
FREE CASH FLOW
Cash From Operating Activities	-$325.5K	-$22.02K	-$528.1K
Capital Expenditures	$35.33K	$95.40K	$539.9K
Free Cash Flow	-$360.8K	-$117.4K	-$1.068M
YoY Change	-262.46%	127.82%	107.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001657214
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Land Available For Sale LandAvailableForSale		usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross		usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet		usd
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost		usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2021Q4	ILAL	Convertible Notes Net Of Debt Discounts ConvertibleNotesNetOfDebtDiscounts		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	ILAL	Loss From Related Party Debt Extinguishment LossFromRelatedPartyDebtExtinguishment		usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	ILAL	Loss From Related Party Debt Extinguishment LossFromRelatedPartyDebtExtinguishment		usd
CY2022	ILAL	Fair Value Of Commitment Shares FairValueOfCommitmentShares		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt		usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
CY2022	ILAL	Increase Decrease In Accrued Interest On Note Receivable IncreaseDecreaseInAccruedInterestOnNoteReceivable		usd
CY2022	ILAL	Increase Decrease In Cost Of Land Sold IncreaseDecreaseInCostOfLandSold		usd
CY2021	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty		usd
CY2022	ILAL	Cash Payment To Collaborative Agreement CashPaymentToCollaborativeAgreement		usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	ILAL	Cash Proceeds From Refinancing Net CashProceedsFromRefinancingNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	ILAL	Additions To Fixed Assets Paid By Investor AdditionsToFixedAssetsPaidByInvestor		usd
CY2021	ILAL	Debt Discount From Bifurcated Derivative DebtDiscountFromBifurcatedDerivative		usd
CY2021	ILAL	Debt Discount From Warrants Issued With Debt DebtDiscountFromWarrantsIssuedWithDebt		usd
CY2021	ILAL	Debt Discount DebtDiscount		usd
CY2022	ILAL	Cancellation Of Previously Issued Common Stock CancellationOfPreviouslyIssuedCommonStock		usd
CY2022	ILAL	Accrued Interest On Notes Paid By Related Party AccruedInterestOnNotesPaidByRelatedParty		usd
CY2022	ILAL	Common Stock Issued With Debt Modification CommonStockIssuedWithDebtModification		usd
CY2022	ILAL	Common Stock Issued In Settlement Of Related Party Debt CommonStockIssuedInSettlementOfRelatedPartyDebt		usd
CY2022	ILAL	Common Stock Issued As Consideration For Equity Method Investment CommonStockIssuedAsConsiderationForEquityMethodInvestment		usd
CY2022	ILAL	Payment Of Promissory Notes By Related Party PaymentOfPromissoryNotesByRelatedParty		usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#DerivativeLiabilities
CY2021Q4	us-gaap	Share Price SharePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2021Q4	ILAL	Convertible Notes Discounts ConvertibleNotesDiscounts		usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Canceled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageCanceled
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermExercised
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56111
CY2022	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL LAND ALLIANCE, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3752361
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 10th Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92101
CY2022	dei	City Area Code CityAreaCode	(877)
CY2022	dei	Local Phone Number LocalPhoneNumber	661-4811
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2022	dei	Trading Symbol TradingSymbol	ILAL
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	8657680	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64943897	shares
CY2022	dei	Auditor Firm AuditorFirmId	2738
CY2021	dei	Auditor Firm AuditorFirmId	200
CY2022	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2022	dei	Auditor Location AuditorLocation	Houston, TX
CY2021	dei	Auditor Name AuditorName	HASKELL & WHITE LLP
CY2021	dei	Auditor Location AuditorLocation	Irvine, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49374	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56590	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	314090	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49198	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	251665	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	98572	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	622345	usd
CY2022Q4	us-gaap	Land Land	203419	usd
CY2021Q4	us-gaap	Land Land	203419	usd
CY2021Q4	us-gaap	Land Available For Sale LandAvailableForSale	647399	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	863745	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	915884	usd
CY2022Q4	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	1877	usd
CY2021Q4	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	2682	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	852020	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	103234	usd
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2511830	usd
CY2022Q4	us-gaap	Assets Assets	1167613	usd
CY2021Q4	us-gaap	Assets Assets	5858813	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	675202	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	802200	usd
CY2022Q4	ILAL	Accounts Payable And Accrued Liabilities Related Party AccountsPayableAndAccruedLiabilitiesRelatedParty	189266	usd
CY2021Q4	ILAL	Accounts Payable And Accrued Liabilities Related Party AccountsPayableAndAccruedLiabilitiesRelatedParty	636168	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	352884	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	178563	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	132841	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	39602	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	85407	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	126663	usd
CY2022Q4	us-gaap	Deposits Deposits	20500	usd
CY2021Q4	us-gaap	Deposits Deposits	20000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	531527	usd
CY2022Q4	ILAL	Convertible Notes Net Of Debt Discounts ConvertibleNotesNetOfDebtDiscounts	558657	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5718595	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2740942	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1735538	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5718595	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4476480	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43499423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43499423	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31849327	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31849327	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43500	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31850	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20233446	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15760772	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25121457	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14703818	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1167613	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5858813	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	522696	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	67806	usd
CY2021	us-gaap	Gross Profit GrossProfit	454890	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1085300	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1782000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4158243	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3107457	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2875818	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	8351000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	4657818	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-8351000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4202928	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	540	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	91624	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-422493	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-168170	usd
CY2022	ILAL	Loss From Related Party Debt Extinguishment LossFromRelatedPartyDebtExtinguishment	-78508	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	18234	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-33992	usd
CY2022	us-gaap	Interest Expense InterestExpense	1532186	usd
CY2021	us-gaap	Interest Expense InterestExpense	800822	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2066639	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-859134	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10417639	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5062062	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35605172	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28186226	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022	ILAL	Stock Issued During Period Value Issued Pursuant To Promissory Notes StockIssuedDuringPeriodValueIssuedPursuantToPromissoryNotes	202275	usd
CY2022	ILAL	Stock Issued During Period Value Pursuant To Consulting Agreements StockIssuedDuringPeriodValuePursuantToConsultingAgreements	1470837	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1300	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1710881	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	984367	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	159664	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-60000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10417639	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1201920	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1201920	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	387109	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	65000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	100000	usd
CY2021	ILAL	Common Stock To Be Issued And Plots Promised For Cash CommonStockToBeIssuedAndPlotsPromisedForCash	29521	usd
CY2021	ILAL	Stock Issued During Period Value Against Accrued Interest Due To Related Party StockIssuedDuringPeriodValueAgainstAccruedInterestDueToRelatedParty	10999	usd
CY2021	ILAL	Cash Payment To Collaborative Agreement CashPaymentToCollaborativeAgreement	100000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	100000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	539935	usd
CY2021	ILAL	Stock Issued During Period Commitment With Promissory Note Value StockIssuedDuringPeriodCommitmentWithPromissoryNoteValue	267700	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	103470	usd
CY2021	ILAL	Stock Issued During Period Value Common Stock Issued With Equitymethod StockIssuedDuringPeriodValueCommonStockIssuedWithEquitymethod	2580000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1739750	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-60000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2129266	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5062062	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10417639	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5062062	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1710881	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2129266	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4158243	usd
CY2022	ILAL	Loss From Related Party Debt Extinguishment LossFromRelatedPartyDebtExtinguishment	-78508	usd
CY2022	ILAL	Fair Value Of Shares Issued For Debt Settlement Modification FairValueOfSharesIssuedForDebtSettlementModification	1470836	usd
CY2021	ILAL	Fair Value Of Shares Issued For Debt Settlement Modification FairValueOfSharesIssuedForDebtSettlementModification	103470	usd
CY2021	ILAL	Fair Value Of Commitment Shares FairValueOfCommitmentShares	136800	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	387108	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10876	usd
CY2022	us-gaap	Depreciation Depreciation	52944	usd
CY2021	us-gaap	Depreciation Depreciation	49673	usd
CY2022	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt	356784	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-422493	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-168170	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-33992	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	458616	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	296541	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-26802	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	314089	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-52467	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-80755	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-34693	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-267560	usd
CY2021	ILAL	Increase Decrease In Accrued Interest On Note Receivable IncreaseDecreaseInAccruedInterestOnNoteReceivable	3234	usd
CY2021	ILAL	Increase Decrease In Cost Of Land Sold IncreaseDecreaseInCostOfLandSold	67806	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-131739	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	909049	usd
CY2022	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty	460976	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	469715	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	44500	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	500	usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-75000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-528061	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1035678	usd
CY2022Q4	ILAL	Working Capital WorkingCapital	5600000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	522050	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-539935	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-722050	usd
CY2022	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash	15000	usd
CY2021	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash	1804750	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1300	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	100000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	390621	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	676938	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	131339	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	982086	usd
CY2022	ILAL	Proceeds From Promissory Notes ProceedsFromPromissoryNotes	773250	usd
CY2021	ILAL	Proceeds From Promissory Notes ProceedsFromPromissoryNotes	288874	usd
CY2021	ILAL	Cash Proceeds From Refinancing Net CashProceedsFromRefinancingNet	368736	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	793187	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	897811	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1060777	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1801147	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7219	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	43419	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56590	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13171	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49371	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56590	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	137863	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	152979	usd
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	29521	usd
CY2022	ILAL	Corporate Expenses Paid By Related Party Advances CorporateExpensesPaidByRelatedPartyAdvances	49145	usd
CY2021	ILAL	Corporate Expenses Paid By Related Party Advances CorporateExpensesPaidByRelatedPartyAdvances	25462	usd
CY2022	ILAL	Dividend On Series B DividendOnSeriesB	60000	usd
CY2021	ILAL	Dividend On Series B DividendOnSeriesB	60000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	905859	usd
CY2021	ILAL	Additions To Fixed Assets Paid By Investor AdditionsToFixedAssetsPaidByInvestor	84614	usd
CY2022	ILAL	Debt Discount From Bifurcated Derivative DebtDiscountFromBifurcatedDerivative	140750	usd
CY2022	ILAL	Debt Discount From Warrants Issued With Debt DebtDiscountFromWarrantsIssuedWithDebt	159664	usd
CY2022	ILAL	Debt Discount DebtDiscount	121694	usd
CY2021	ILAL	Cancellation Of Previously Issued Common Stock CancellationOfPreviouslyIssuedCommonStock	315288	usd
CY2021	ILAL	Accrued Interest On Notes Paid By Related Party AccruedInterestOnNotesPaidByRelatedParty	30934	usd
CY2021	ILAL	Common Stock Issued With Debt Modification CommonStockIssuedWithDebtModification	8970	usd
CY2021	ILAL	Common Stock Issued In Settlement Of Related Party Debt CommonStockIssuedInSettlementOfRelatedPartyDebt	10999	usd
CY2021	ILAL	Common Stock Issued As Consideration For Equity Method Investment CommonStockIssuedAsConsiderationForEquityMethodInvestment	2580000	usd
CY2021	ILAL	Payment Of Promissory Notes By Related Party PaymentOfPromissoryNotesByRelatedParty	111110	usd
CY2022	ILAL	Commitment Shares Issued With Promissory Notes CommitmentSharesIssuedWithPromissoryNotes	202275	usd
CY2021	ILAL	Commitment Shares Issued With Promissory Notes CommitmentSharesIssuedWithPromissoryNotes	130900	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	497535000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-33992000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	531527	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10400000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-500000	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zcKC4Jh8amW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_ztas5ZlN7f68">Reclassification</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain numbers from 2021 have been reclassified to conform with the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1782000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z64zyFWnJjt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zGlR2ntf3j82">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful lives of building.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowance.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived asset for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s equity-method investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	531527	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	531527	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	-0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2022Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P20Y
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	496800	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	522696	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1085300	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9867500	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7030000	shares
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zco0gwCs04r3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zUtJDvO0g7ea">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through December 31, 2022. All of the Company accounts receivable is concentrated with one customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2021	ILAL	Revenue Recognized RevenueRecognized	496797	usd
CY2021Q4	us-gaap	Area Of Land AreaOfLand	20
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	3234	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	103234	usd
CY2022	us-gaap	Acquisition Costs AcquisitionCosts	22050	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	1122050	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	271225	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	850826	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1067164	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1119303	usd
CY2022Q4	ILAL	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildingand Construction BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildingandConstruction	52400	usd
CY2021Q4	ILAL	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildingand Construction BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildingandConstruction	49400	usd
CY2021	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	99000	usd
CY2022	ILAL	Construction Contract For Consideration Funded ConstructionContractForConsiderationFunded	43967	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	23967	usd
CY2021	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	20000	usd
CY2022	ILAL	Customer Funded Additional Amount CustomerFundedAdditionalAmount	41940	usd
CY2022Q4	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	184393	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132254	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	863745	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	915884	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52400	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49700	usd
CY2022	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	1500000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	400000	usd
CY2022Q4	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2021Q4	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4146	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	51462	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1885616	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	1838300	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1885616	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	102762	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1735538	usd
CY2022	ILAL	Aggregate Interest Amount AggregateInterestAmount	142960	usd
CY2022	ILAL	Expenses Paid By Related Party ExpensesPaidByRelatedParty	35740	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	347290	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	771738	usd
CY2022Q4	ILAL	Convertible Notes Discounts ConvertibleNotesDiscounts	213081	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	558657	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	558657	usd
CY2022	ILAL	Repayment Of Promissory From Related Parties RepaymentOfPromissoryFromRelatedParties	68096	usd
CY2021	ILAL	Repayment Of Promissory From Related Parties RepaymentOfPromissoryFromRelatedParties	88000	usd
CY2022	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	3000000	shares
CY2021	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	3000000	shares
CY2022	ILAL	Commitment To Purchase Of Land CommitmentToPurchaseOfLand	The land project consisting of 20 acres to be acquired from Baja Residents Club (a Company controlled by our CEO Roberto Valdes) and developed into Valle Divino resort in Ensenada, Baja California, the acquisition of title to the land for this project is subject to approval from the Mexican government in Baja, California
CY2022Q4	us-gaap	Area Of Land AreaOfLand	20
CY2022Q4	ILAL	Net Budget NetBudget	1556000	usd
CY2022Q4	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	816047	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	740000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	496800	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43499423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43499423	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31849327	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31849327	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	150000000	shares
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	65000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3850000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3450000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.13
CY2022	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P5Y
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1300000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2022	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4521875	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2900000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.43
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M6D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3150000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.30
CY2021	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y5M4D
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.05
CY2021	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1	P1Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1200000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.58
CY2021	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Canceled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageCanceled	P0Y6M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3850000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1487500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	716000	usd
CY2022	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Vesting Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermVestingPeriod	P0Y7M2D
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	300000	usd
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	6000000	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	4521875	shares
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y10M17D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.34
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4521875	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y10M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.34
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.48	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.75	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.59	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.62	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0034	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0085	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0038	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0087	pure
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate	0	pure
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3180000	shares
CY2021Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.69
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P5Y29D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	687500	shares
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.80
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted	P4Y2M23D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3867500	shares
CY2022Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.71
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding	P4Y1M9D
CY2022Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	3867500	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	460000	shares
CY2020Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.38
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P0Y8M12D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	3180000	shares
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.69
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted	P5Y29D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	160000	shares
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.31
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermExercised	P0Y2M23D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	300000	shares
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice	0.42
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3180000	shares
CY2021Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.69
CY2021	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding	P5Y29D
CY2021Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	3180000	shares
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	21400000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11000000.0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure

Files In Submission

Name	View Source	Status
0001493152-23-023833-index-headers.html	Edgar Link	pending
0001493152-23-023833-index.html	Edgar Link	pending
0001493152-23-023833.txt	Edgar Link	pending
0001493152-23-023833-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
ilal-20221231.xsd	Edgar Link	pending
logo_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
ilal-20221231_cal.xml	Edgar Link	unprocessable
ilal-20221231_def.xml	Edgar Link	unprocessable
ilal-20221231_lab.xml	Edgar Link	unprocessable
ilal-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2023 Q2 Form 10-K Financial Statement

#000149315223023833 Filed on July 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2023 Q2 Form 10-K Financial Statement

#000149315223023833 Filed on July 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal